⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DAWN News
Day One Biopharmaceuticals, Inc. Common Stock
Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance
globenewswire.com
DAWN
Day One Completes Acquisition of Mersana Therapeutics
globenewswire.com
DAWN
MRSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alexander & Baldwin, Inc. (NYSE - ALEX), United Security Bancshares (Nasdaq - UBFO), Udemy, Inc. (Nasdaq - UDMY), Mersana Therapeutics, Inc. (Nasdaq - MRSN)
globenewswire.com
ALEX
UDMY
UBFO
MRSN
COUR
CWBC
DAWN
Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
DAWN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mersana Therapeutics, Inc. (Nasdaq - MRSN), Cidara Therapeutics, Inc. (Nasdaq - CDTX), Cadence Bank (NYSE – CADE)
globenewswire.com
MRSN
CDTX
CADE
DAWN
MRK
HBAN
Day One Announces Three Year Follow-Up Data From OJEMDA™ (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting
globenewswire.com
DAWN
Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference
globenewswire.com
DAWN
Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases
globenewswire.com
DAWN
Day One Announces New OJEMDA™ (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting
globenewswire.com
DAWN
Day One Reports Third Quarter 2025 Financial Results and Corporate Progress
globenewswire.com
DAWN